Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Fatigue × Testosterone × Clear all

Phase

Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 7 Neoplasms 4 Hypogonadism 2 Testicular Neoplasms 1 Sexuality 1 Neoplasm Metastasis 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Fatigue 1 Eunuchism 1 Carcinoma, Intraductal, Noninfiltrating 1

Interventions

Modafinil 7 Methylphenidate 4 regorafenib 2 Saline Solution 2 Physical Therapy Modalities 2 Exercise 2 Dexamethasone 2 reparixin 1 ofatumumab 1 epoetin beta 1 eicosapentaenoic acid ethyl ester 1 eicosapentaenoic acid ethanolamide 1 clazakizumab 1 caffeine, sodium benzoate drug combination 1 Yoga 1 Walking 1 Waiting Lists 1 Urinalysis 1 Thalidomide 1 Testosterone 1 Sugars 1 Sodium Chloride 1 Proton Pump Inhibitors 1 Patient Reported Outcome Measures 1 Megestrol Acetate 1 Lenalidomide 1 Lactose 1 Huang Qi 1 Hematologic Tests 1 Geritol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04301765 2025-03-11

TEMEC

Seattle Institute for Biomedical and Clinical Research

Phase 2 Recruiting

Eunuchism, Fatigue, Hypogonadism, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡